These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6092797

  • 1. GABAergic influence on the effects of elymoclavine on exploratory behaviour of rats in open field.
    Georgiev V, Getova D, Petkov V.
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):423-7. PubMed ID: 6092797
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of the angiotensin II effects on exploratory behavior of rats in open field. III. Modulatory role of GABA.
    Georgiev V, Getova D, Opitz M.
    Methods Find Exp Clin Pharmacol; 1991 Aug; 13(1):5-9. PubMed ID: 1870357
    [Abstract] [Full Text] [Related]

  • 3. Effect of elymoclavine on open field behaviour of rats and pharmacological analysis of its catecholaminergic mechanisms.
    Georgiev V, Getova D.
    Methods Find Exp Clin Pharmacol; 1983 Jun; 5(5):281-5. PubMed ID: 6312220
    [Abstract] [Full Text] [Related]

  • 4. Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
    Petkova B, Georgiev V, Kambourova T.
    Acta Physiol Pharmacol Bulg; 1991 Jun; 17(2-3):84-90. PubMed ID: 1819920
    [Abstract] [Full Text] [Related]

  • 5. On the pharmacology of the ergot alkaloid elymoclavine.
    Petkov V, Georgiev V, Roussinov K, Grigorov I, Slokoska L, Angelova M, Lazarova M, Getova D, Todorov S, Radomirov R.
    Biomed Biochim Acta; 1984 Jun; 43(11):1305-16. PubMed ID: 6442580
    [Abstract] [Full Text] [Related]

  • 6. On some central effects of elymoclavine.
    Roussinov K, Georgiev V, Petkov V, Lazarova M, Petkova B, Shopova S, Markovska V, Getova D, Draganova S.
    Acta Physiol Pharmacol Bulg; 1984 Jun; 10(4):28-35. PubMed ID: 6442955
    [Abstract] [Full Text] [Related]

  • 7. [Influence of GABAergic neurons in the brain on central effects of kainate on the cardiovascular system].
    Zhang L, Zhang DS, Zhang SS.
    Yao Xue Xue Bao; 1991 Jun; 26(6):411-4. PubMed ID: 1665002
    [Abstract] [Full Text] [Related]

  • 8. Spinal and supraspinal components of GABAergic inhibition of the micturition reflex in rats.
    Maggi CA, Furio M, Santicioli P, Conte B, Meli A.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):998-1005. PubMed ID: 3559989
    [Abstract] [Full Text] [Related]

  • 9. A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats.
    Paul V, Krishnamoorthy MS.
    Indian J Physiol Pharmacol; 1990 Apr; 34(2):139-42. PubMed ID: 2147669
    [Abstract] [Full Text] [Related]

  • 10. The influence of gabaergic system on cataleptogenic action of analgesics and haloperidol.
    Malec D, Langwiński R.
    Pol J Pharmacol Pharm; 1986 Apr; 38(5-6):501-7. PubMed ID: 3575168
    [Abstract] [Full Text] [Related]

  • 11. [Neurophysiological mechanisms of the action of GABA-tropic agents on brain structures].
    Krauz VA, Mamchur VI, Iarosh AK.
    Farmakol Toksikol; 1987 Apr; 50(6):30-3. PubMed ID: 2830132
    [Abstract] [Full Text] [Related]

  • 12. Effects of electroconvulsive shock on central GABA-ergic mechanisms.
    Wielosz M, Stelmasiak M, Ossowska G, Kleinrok Z.
    Pol J Pharmacol Pharm; 1985 Apr; 37(2):113-22. PubMed ID: 2995953
    [Abstract] [Full Text] [Related]

  • 13. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
    Georgiev V.
    Pol J Pharmacol Pharm; 1990 Apr; 42(6):553-62. PubMed ID: 1983291
    [Abstract] [Full Text] [Related]

  • 14. GABAB receptor-mediated inhibition of serotonin release in the rat brain.
    Schlicker E, Classen K, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):99-105. PubMed ID: 6206406
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological studies on sympathoinhibition produced by the medial medullary depressor region: proposed gamma-aminobutyric acid involvement in inhibition of somatosympathetic reflexes.
    Taylor DG, Taylor KA, Antonaccio MJ.
    J Pharmacol Exp Ther; 1982 Sep; 222(3):517-25. PubMed ID: 6286921
    [No Abstract] [Full Text] [Related]

  • 16. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M, Gale K.
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of gamma-aminobutyric acid on the development of catatonia-like states in mice].
    Kudriavtseva NN, Bakshtanovskaia IV.
    Farmakol Toksikol; 1989 Apr; 52(1):17-20. PubMed ID: 2707411
    [Abstract] [Full Text] [Related]

  • 19. [A pharmacological analysis of the role of GABA- and opioidergic systems in the development of brain edema].
    Novikov VE, Iasnetsov VV, Sharov AN.
    Biull Eksp Biol Med; 1992 Jul; 114(8):163-5. PubMed ID: 1334728
    [Abstract] [Full Text] [Related]

  • 20. The influence of GABA-ergic system on clonidine analgesia in rats.
    Przesmycki K, Dzieciuch J, Kleinrok Z.
    Pol J Pharmacol; 1994 Jul; 46(5):409-15. PubMed ID: 7894527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.